YoVDO

Pre-Clinical Investigation of a New PD-L1 B-Cell Epitope Peptide Vaccine PDL1-Vaxx

Offered By: Labroots via YouTube

Tags

Immunotherapy Courses Oncology Courses Immunology Courses

Course Description

Overview

Save Big on Coursera Plus. 7,000+ courses at $160 off. Limited Time Only!
Explore a groundbreaking 11-minute webinar presented by Jay Overholser, Lab Manager in Professor Pravin Kaumaya's lab at The Ohio State University Wexner Medical Center. Delve into the pre-clinical investigation of a novel PD-L1 B cell epitope peptide vaccine, PDL1-Vaxx, and its potential implications in cancer immunotherapy. Gain insights from Overholser's expertise in the Department of Obstetrics and Gynecology as he discusses the development and preliminary findings of this innovative vaccine approach. Learn about the latest advancements in cancer research and how this new peptide vaccine could potentially enhance immune responses against tumors.

Syllabus

Pre Clinical Investigation of a New PD L1 B Cell Epitope Peptide Vaccine PDL1 Vaxx and its...


Taught by

Labroots

Related Courses

Practical tips to improve Asian American participation in cancer clinical trials
Stanford University via Coursera
Thoracic Oncology
University of Michigan via Coursera
Medical Genomics 101
Davidson College via edX
Diagnosis and prognosis biomarkers in global health
Institut Pasteur via France Université Numerique
Medical Cannabis for Pain Control
Technion - Israel Institute of Technology via Coursera